Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion.

Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion.
复制标题

DOI:
10.1002/humu.21157
复制
发表时间:
2010-02
期刊:
影响因子:
3.9
通讯作者:
Beggs, Alan H.
Beggs, Alan H.
中科院分区:
医学2区
文献类型:
--
作者:
Lawlor, Michael W.;DeChene, Elizabeth T.;Roumm, Emily;Geggel, Amelia S.;Moghadaszadeh, Behzad;Beggs, Alan H.

文献摘要

参考文献

被引文献

相似文献

先天性纤维型失调(CFTD)是一种罕见的先天性肌病,其特征是张力低下和全身肌肉无力。在没有其他明显病理表现的情况下,CFTD的病理诊断是基于至少12%的1型纤维萎缩。在一小部分CFTD病例中发现了ACTA1和SEPN1基因突变。肌原肌球蛋白3基因TPM3在罕见的线状肌病病例中发生突变,这些病例通常表现为1型纤维萎缩伴线状棒,最近发现TPM3基因突变也可导致CFTD。我们在临床诊断为CFTD、线状肌病和不明先天性肌病的患者中筛选TPM3基因。13例CFTD患者中的6例以及1例线状肌病患者中发现了TPM3突变。对诊断为CFTD的患者的肌肉活检的回顾显示,TPM3突变的患者都表现出明显的纤维大小失调,没有1型纤维优势。一些突变阴性的病例表现出其他异常,如中央核和中央核。这些结果支持了CFTD诊断在指导基因检测过程中的效用。
Congenital fiber type disproportion (CFTD) is a rare congenital myopathy characterized by hypotonia and generalized muscle weakness. Pathologic diagnosis of CFTD is based on the presence of type 1 fiber hypotrophy of at least 12% in the absence of other notable pathological findings. Mutations of the ACTA1 and SEPN1 genes have been identified in a small percentage of CFTD cases. The muscle tropomyosin 3 gene, TPM3, is mutated in rare cases of nemaline myopathy that typically exhibit type 1 fiber hypotrophy with nemaline rods, and recently mutations in the TPM3 gene were also found to cause CFTD. We screened the TPM3 gene in patients with a clinical diagnosis of CFTD, nemaline myopathy, and with undefined congenital myopathies. Mutations in TPM3 were identified in 6 out of 13 patients with CFTD, as well as in one case of nemaline myopathy. Review of muscle biopsies from patients with diagnoses of CFTD revealed that patients with a TPM3 mutation all displayed marked disproportion of fiber size, without type 1 fiber predominance. Several mutation-negative cases exhibited other abnormalities, such as central nuclei and central cores. These results support the utility of the CFTD diagnosis in directing the course of genetic testing.
DOI: 10.1097/nen.0b013e318183a44f
发表时间: 2008-09-01
影响因子: 3.2
作者:
Ilkovski, Biljana;Mokbel, Nancy;Cooper, Sandra T.
通讯作者: Cooper, Sandra T.
DOI: 10.1212/01.wnl.0000046585.81304.bc
发表时间: 2003-02-25
期刊: NEUROLOGY
影响因子: 9.9
作者:
Ryan, MM;Ilkovski, B;Beggs, AH
通讯作者: Beggs, AH
DOI: 10.1093/jnen/62.10.977
发表时间: 2003-10-01
影响因子: 3.2
作者:
Clarke, NF;North, KN
通讯作者: North, KN
DOI: 10.1002/ana.20260
发表时间: 2004-11-01
影响因子: 11.2
作者:
Laing, NG;Clarke, NF;Nonaka, I
通讯作者: Nonaka, I
DOI: 10.1016/j.nmd.2007.01.017
发表时间: 2007-04-01
影响因子: 2.8
作者:
Penisson-Besnier, Isabelle;Monnier, Nicole;Laing, Nigel
通讯作者: Laing, Nigel